Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active ShortageTier 3 — Critical

VEPESID

CHEPLAPHARM ARZNEIMITTEL GMBH

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of VEPESID in Canada?

Yes. VEPESID 50MG has an active shortage reported to Health Canada (last updated October 27, 2026).

Why is VEPESID not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will VEPESID be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist
StatusActive Shortage
Same-ingredient products on fileNone found
Affected strength50MG
Report last updated2026-10-27
Checked by MedShort2026-11-12

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Health Canada classes this as a Tier 3 shortage, its highest-impact category. If you rely on this medication, talk to your pharmacist or care team now rather than waiting for your supply to run low.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

00616192

Strength

50MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

ETOPOSIDE

See all ETOPOSIDE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History